The subjects were selected from populations at the First Affiliated Hospital of Nanjing Medical University (Nanjing, China) from April 2019 through January 2020. Written informed consent to participate was obtained from each of the enrolled subjects. The study protocol was registered at ClinicalTrial. gov (NCT04255524), and was approved by the Institutional Review Board of First Affiliated Hospital of Nanjing Medical University and followed the tenets of the Declaration of Helsinki.
Study Subjects
Subjects were divided into two groups based on the spherical equivalent (SE), which was calculated as the spherical dioptric power plus one-half of the cylindrical dioptric power. Subjects with a SE between − 10.0 diopters (D) and − 6.0D was allocated in high myopia group, while subjects with a SE between − 6.0D and − 0.5D was in mild-moderate myopia group.
Each subject underwent comprehensive ophthalmic examinations including slit-lamp biomicroscopy using Haag-Streit BM 900 slit-lamp microscope (Haag-Streit, Köniz, Switzerland), intraocular pressure using Canon TX-20 non-contact tonometer (Canon, Tokyo, Japan), best-corrected visual acuity, refraction test using autorefractometer RC-5000 (Tomey, Nagoya, Japan) and phoropter RT-5100 (Nidek, Tokyo, Japan), AL measurement using Nidek-AL Scan optical biometry (Nidek, Gamagori, Japan), fundus color photography and red-free fundus photography using Canon CR-2 Plus AF non-mydriatic retinal camera (Canon, Tokyo, Japan), and OCTA using Optovue Angio Vue™ System (Optovue, Fremont, California, USA). All the examinations were completed by one professionally trained ophthalmologist (J.L).
The main inclusion criteria were subjects (1) between 18–40 years old, (2) with a best-corrected visual acuity of ≥ 20/20 and a SE ranging from − 0.5 to -10.0 D, (3) with an intraocular pressure of < 21 mmHg and with < 5 mmHg difference between the two eyes, (4) with no history of elevated intraocular pressure, and no glaucomatous appearance. The absence of glaucomatous appearance was defined as follows: cup-disc ratio < 0.5 with ≤ 0.2 difference between the two eyes, an intact neuroretinal rim, no disc hemorrhages, notches or localized pallor, and normal retinal nerve fiber layer thickness without any defects. The exclusion criteria were (1) reluctance of signing informed consent or receiving consecutive following-up, (2) incapability of undergoing ocular examinations or producing good-quality images, (3) astigmatism beyond ± 4.0 D, (4) any history of intraocular or refractive surgery, (5) the presence of any retinal or neurological diseases (other than myopic degeneration), or opaque media, or glaucoma.
Octa And Determination Of The Presence Of a MvD
The optic nerve and peripapillary area were imaged using a commercially available spectral domain Optovue Angio Vue™ OCTA system (Optovue, USA) operating at a central wavelength of 840 nm, an acquisition speed of 70,000 A-scans per second, and axial and transverse resolutions of 5 and 15 µm in tissue, respectively. Scans were obtained from 4.5 × 4.5-mm cubes, with each cube consisting of 400 clusters of 2 repeated B-scans centered on the optic disc. Automatic layer segmentation in “Angio-disc” pattern performed by the built-in software controlling the OCT instrument generated scanning laser ophthalmoscope images of the disc and peripapillary region and en-face projections to visualize the vasculature and structure of Vitreous/Retina layer from vitreous body to outer plexiform layer (50 µm below internal limiting membrane), retinal posterior capillary layer from internal limiting membrane to nerve fiber layer, and Choroid layer below RPE.
All the OCTA images were exported in PNG format (Fig. 1A). The color fundus image, scanning laser ophthalmoscope image, and OCTA image of each participant were carefully evaluated by two ophthalmologists (J.L and Y.Y) to contour the PPA-α and PPA-β zone (Fig. 1B&C) under the supervision of two veteran ophthalmologists (Q.L and P.X). On the OCTA images, we manually defined “pixel” as the minimum unit of area measurement, that is, a pixel was equal to a cluster of a 4.5 × 4.5-mm cube (126.5625 µm2). When assessing MvD, the data set of OCTA images were then transferred to Nanjing University of Science and Technology (Nanjing, China). The appropriate threshold was identified as regions with a grey value less than 50 and an area exceeding 20 pixels (Fig. 1A). The area of MvD and PPA-β zone was calculated by PyCharm software counting the number of pixels that met this standard. Large vessels were removed from the OCTA image in advance, without whose influence the mean density of choroidal blood flow could be more accurately calculated as the area occupied by blood signals in the scanned region. All of the included OCT B-scan images had scan quality scores of ≥ 6/10. Any image with a double vessel pattern, motion artifacts, or segmentation errors extending more than three lines was excluded from the analysis.
Data Analysis
All data were expressed as the mean ± standard deviations and were analyzed statistically using SPSS software (version 25.0; SPSS, Chicago, Illinois, USA). Demographic, ocular, and systemic characteristics were compared between groups using the independent-samples t-test for numerical variables. We used analysis of variance to validate data accuracy if a measurement should be repeated for at least three times. Correlations between MvD area and age, SE, AL and the area of PPA-β zone were determined using the Spearman correlation test. The criterion for statistical significance was P < 0.05.